Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Progress in AIDS vaccine development

¹Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-7620, USA.

International Archives of Allergy and Immunology

|December 1, 1995

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Publish and Be Sued? Potential Liability for Infringement Arising through Academic Research.

Tissue engineering·2009

Same author

HIV vaccine development.

Developments in biologicals·2002

Same author

Progress in HIV vaccine development.

Current opinion in pharmacology·2002

Same author

Optimism is growing as researchers move toward an AIDS vaccine.

AIDS alert·2001

Same author

Season of birth in females with anorexia nervosa in Northeast Scotland.

The International journal of eating disorders·2001

Same author

Immunization. Update: search for an AIDS vaccine.

The AIDS reader·2000

Same journal

Differences in Reported Anaphylaxis Associated With Common Nonsteroidal Anti-inflammatory Drugs: A Pharmacovigilance Study.

International archives of allergy and immunology·2026

Same journal

Association of Serum Galectin-3 Binding Protein with Acute Exacerbation, Inflammation, and Airway Remodeling in Pediatric Asthma.

International archives of allergy and immunology·2026

Same journal

Effectiveness of a Provincial Law to Improve Epinephrine Use for Anaphylaxis in Schools in Alberta, Canada: A Pre-Post Study.

International archives of allergy and immunology·2026

Same journal

Rab27 a regulates dendritic cell immune tolerogenic capacity.

International archives of allergy and immunology·2026

Same journal

Burden of Hereditary Angioedema in Adults: Impact of Disease and Patient Characteristics.

International archives of allergy and immunology·2026

Same journal

Predictors of Treatment Response to Omalizumab in Children with Chronic Spontaneous Urticaria: A Real World Study.

International archives of allergy and immunology·2026

See all related articles

Developing effective human immunodeficiency virus (HIV) vaccines presents unique challenges, leading to parallel evaluation of diverse vaccine designs. Promising candidates in early human trials show safety and immunogenicity, advancing to efficacy testing.

Area of Science:

Vaccinology
Immunology
Infectious Diseases

Background:

Developing an effective human immunodeficiency virus (HIV) vaccine is complex due to unique scientific challenges.
Multiple vaccine strategies are under investigation concurrently to address these hurdles.

Purpose of the Study:

To provide an overview of the current landscape of HIV vaccine development.
To highlight the parallel evaluation of various traditional and novel vaccine designs.

Main Methods:

Review of ongoing and upcoming human clinical trials for candidate HIV vaccines.
Assessment of safety and immunogenicity data from Phase I/II trials.

Main Results:

Several vaccine candidates, including monomeric proteins, poxvirus vectors, peptides, and particle-based vaccines, are in or entering human trials.

Related Experiment Videos

All evaluated candidates in Phase I/II trials have demonstrated safety and immunogenicity.

Conclusions:

The diverse range of HIV vaccine candidates shows promise in early-stage human trials.
Further 'test of concept' clinical trials are planned to determine the efficacy of the most advanced designs.